Cannabis-based drug for childhood epilepsy approved for use in UK
The first cannabis-based medicine for childhood epilepsy is expected to be available soon in the UK and the rest of Europe after its UK manufacturer, GW Pharmaceuticals, received the green light from European authorities. Read more »
White House Drug Officials Say Legal Marijuana Is Up To States
Two top federal drug officials, including the White House drug czar, recently said that marijuana legalization should be left up to states. The comments stand out coming from the Office of National Drug Control Policy (ONDCP), which has historically played a central role in defending blanket federal prohibition. Read more »
Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says
Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020. Read more »
CBO: Cannabis Banking a Net Benefit for Government
Earlier this year, the Congressional Budget Office (CBO) reported that a proposed bill to give the cannabis industry access to banking and other financial services, known as the SAFE Banking Act (H.R. 1595) (SAFE), would save the government money while dramatically increasing deposits in the nation’s banks. Read more »